Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats

International Journal of Immunopharmacology

Volumn 11, Issue 8, 1989, Pages 921-929

  Thoenes, G H ^a   Sitter, T ^a   Langer, K H ^b   Bartlett, R R ^c   Schleyerbach, R ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Department of Pathology Hoeschst AG 6000 Frankfurt/M 80 Federal Republic of Germany ^*  (Germany)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOSPORIN A; INDOMETACIN; LEFLUNOMIDE; NAPROXEN; PREDNISOLONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; HISTOCHEMISTRY; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TUBULE BASEMENT MEMBRANE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BASEMENT MEMBRANE; CYCLOSPORINS; ISOXAZOLES; KIDNEY TUBULES; NEPHRITIS, INTERSTITIAL; OXAZOLES; RATS; RATS, INBRED BN;

EID: 0024787777     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(89)90114-8     Document Type: Article

References (27)

1. The effect of daily cyclophosphamide administration on the development and extent of primary experimental interstitial nephritis in rats
2. Induction, characterization, and cell transfer of autoimmune tubulointerstial nephritis
3. Immunopharmacological profile of a novel isoaxazol derivative, HWA 486, witt potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the rat
4. Immunologic, histologic, and ultrastructural studies in autoimmune MRL/1 mice
5. Immunopharmacological profile of HWA 486, a novel isoxazol derivative — II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone or cyclosporin A
6. Development of autoimmunity in MRL71pr mice and the effects of drugs on this murine disease
7. Essentials of cyclosporin A. A novel type of antilymphocyte agent
8. Effect of cyclosporin A on autoimmune tubulointerstitial nephritis in the Brown Norway rat
9. Genetic control of autoimmune tubulointerstitial nephritis in rats
10. Interstitial nephritis in rats immunized with heterologous tubular basement membrane
11. Effects of leflunomide (HWA 486) on mediators of the immune response
12. CS-A therapy in MRL-lpr/lpr mice: Amelioration of immunopathology despite autoantibody production
13. Experimental strategies for the study of cellular immunity in renal disease
14. Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis
15. Types of kidney lesions in experimental (anti-TBM) interstitial nephritis. Electronmicroscopic findings
16. Disease modifying activity of HW 486 on the development of SLE in MRL/1-mice
17. The use of the murine chronic graft versus host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery
18. Experimental autoimmune renal tubulointerstial disease
19. Effects of cyclosporin A on the development of immune-mediated interstitial nephritis
20. Transfer of experimental autoimmune renal cortical tubular and interstial disease in guinea pigs by serum
21. Immunopathologic study of an autoimmune tubular and interstitial renal disease in Brown Norway rats
22. Autoimune cell-mediated tubulointerstial nephritis induced in Lewis rats by renal antigens
23. The importance of the renal interstitium for kidney function
24. Cyclosporin A inhibits autoimmune experimental tubulointerstitial nephritis
25. Inhibition of the neutrophilic infiltrate of experimental tubulointerstitial nephritis in the Brown-Norway rat by decomplementation
26. Murine interstitial nephritis II. The adoptive transfer of disease with immune T-lymphocytes produces phenotypically complex interstitial lesion
27. Characterization of antitubular basement membrane antibodies in rats